Huiling Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Circular RNAs in diseases
- 14-3-3 protein interactions
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 9
- RNA modifications and cancer 8
- Cancer-related gene regulation 5
- 14-3-3 protein interactions 4
- RNA Research and Splicing 3
- Oncology 19
- Cancer-related Molecular Pathways 12
- Co-authors
- Weiyi Fang (23 shared papers)François X. Claret (6 shared papers)Yunbao Pan (4 shared papers)Ruiying Zhao (4 shared papers)Xin Li (7 shared papers)Mong‐Hong Lee (6 shared papers)Kai‐Tai Yao (5 shared papers)Zhen Liu (4 shared papers)
- Journals
- Oncogene (4 papers)Cancer Research (3 papers)Journal of Translational Medicine (3 papers)Acta Biochimica et Biophysica Sinica (3 papers)Molecular Cancer (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Huiling Yang
63 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 454
- Molecular Biology 1.1k
- Oncology 405
- Aging 19
- Molecular Medicine 49
Countries citing papers authored by Huiling Yang
This map shows the geographic impact of Huiling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Yang more than expected).
Fields of papers citing papers by Huiling Yang
This network shows the impact of papers produced by Huiling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Yang. The network helps show where Huiling Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiling Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 147 | |
| 2 | 2013 | 112 | |
| 3 | 2010 | 111 | |
| 4 | 2015 | 104 | |
| 5 | 2011 | 83 | |
| 6 | 2012 | 74 | |
| 7 | 2006 | 73 | |
| 8 | 2005 | 70 | |
| 9 | 2012 | 64 | |
| 10 | 2014 | 55 | |
| 11 | 2010 | 55 | |
| 12 | 2014 | 53 | |
| 13 | 2007 | 46 | |
| 14 | 2014 | 41 | |
| 15 | 2006 | 41 | |
| 16 | 2021 | 40 | |
| 17 | 2013 | 35 | |
| 18 | 2009 | 33 | |
| 19 | 2016 | 32 | |
| 20 | 2013 | 31 |
About Huiling Yang
Huiling Yang is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Cell Biology, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Ubiquitin and proteasome pathways (9 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers), Cancer-related gene regulation (5 papers), 14-3-3 protein interactions (4 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (454 citations), Molecular Biology (1.1k citations), Oncology (405 citations), Aging (19 citations) and Molecular Medicine (49 citations). Huiling Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weiyi Fang, François X. Claret, Yunbao Pan, Ruiying Zhao, Xin Li, Mong‐Hong Lee, Kai‐Tai Yao, Zhen Liu, Weiren Luo and Zhen Liu. Their work appears in journals such as Oncogene, Cancer Research, Journal of Translational Medicine, Acta Biochimica et Biophysica Sinica and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.